scispace - formally typeset
Open AccessJournal ArticleDOI

mTORC1 Links Protein Quality and Quantity Control by Sensing Chaperone Availability

Reads0
Chats0
TLDR
It is demonstrated that cells distinguish moderate reductions in protein quality from severe protein misfolding using molecular chaperones to differentially regulate mTORC1 signaling, and the tight linkage between protein quality and quantity control provides a plausible mechanism coupling protein mis folding with metabolic dyshomeostasis.
Citations
More filters
Journal ArticleDOI

TORC1‐mediated sensing of chaperone activity alters glucose metabolism and extends lifespan

TL;DR: The results set a novel paradigm for the role of proteostasis in aging: modulation of the misfolded protein level can affect cellular metabolic features as well as mitochondrial activity and consequently modify lifespan.
Journal ArticleDOI

The role of mTOR in age-related diseases.

TL;DR: A review of recent insights into the mTOR signalling pathway, including its regulation and its influence on various hallmarks of ageing at the cellular level is provided in this article, where the authors provide an overview of the recent insights.
Journal ArticleDOI

Direct imaging of the recruitment and phosphorylation of S6K1 in the mTORC1 pathway in living cells.

TL;DR: It is demonstrated how FRET-FLIM imaging technology can be used to show localisation of S6K1 phosphorylation in living cells and hence a key site of action of inhibitors targeting mTOR phosphorylated cells.
Journal ArticleDOI

Therapeutic Manipulation of Ageing: Repurposing Old Dogs and Discovering New Tricks.

TL;DR: This review summarises a sample of the most promising efforts to deliver the products of ageing research to the clinic as well as the development of novel therapeutics to target ageing.
References
More filters
Journal ArticleDOI

TOR signaling in growth and metabolism.

TL;DR: The physiological consequences of mammalianTORC1 dysregulation suggest that inhibitors of mammalian TOR may be useful in the treatment of cancer, cardiovascular disease, autoimmunity, and metabolic disorders.
Journal ArticleDOI

mTOR Interacts with Raptor to Form a Nutrient-Sensitive Complex that Signals to the Cell Growth Machinery

TL;DR: It is reported that mTOR forms a stoichiometric complex with raptor, an evolutionarily conserved protein with at least two roles in the mTOR pathway that through its association with mTOR regulates cell size in response to nutrient levels.
Journal ArticleDOI

TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling

TL;DR: It is shown that TSC1–TSC2 inhibits the p70 ribosomal protein S6 kinase 1 and activates the eukaryotic initiation factor 4E binding protein 1 (4E-BP1, an inhibitor of translational initiation) and these functions are mediated by inhibition of the mammalian target of rapamycin (mTOR).
Journal ArticleDOI

Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton.

TL;DR: It is found that the rictor-mTOR complex modulates the phosphorylation of Protein Kinase C alpha (PKCalpha) and the actin cytoskeleton, suggesting that this aspect of TOR signaling is conserved between yeast and mammals.
Related Papers (5)